Skip to main content
. 2016 Jul 10;2016:7340641. doi: 10.1155/2016/7340641

Table 4.

Adverse events.

Group 1 Group 2
Weeks 0 to 7 Weeks 8 to 16 Weeks 0 to 7 Weeks 8 to 16
Pirfenidone Conventional treatment Conventional treatment Pirfenidone
Osteomyelitis 4 (eliminated) 0 6 (eliminated) 0
Hypergranulation 0 0 0 1
Thyroid carcinoma 0 0 1 (eliminated) 0

Total AE 4 0 7 1